Helmut Deissler
Ulm, BW 89075, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Sitagliptin does not interfere with VEGF-A signaling in retinal endothelial cells in vitro.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: November 25, 2025
Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: July 31, 2025
pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review).
Journal: Biomedical reports
Published: July 12, 2021
Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure.
Journal: Journal of diabetes research
Published: November 14, 2019
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.
Journal: International journal of cancer
Published: July 14, 2017
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues.
Journal: Expert opinion on drug safety
Published: November 17, 2015
VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Journal: Experimental eye research
Published: March 13, 2013
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: February 15, 2013
Identification of alternative transcripts of rat CD9 expressed by tumorigenic neural cell lines and in normal tissues.
Journal: Genetics and molecular biology
Published: November 15, 2012
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Journal: PLoS genetics
Published: September 07, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 26, 2012
Last Updated: 09/26/2026